|
BB BIOTECH is banking on genetics. The investment firm funds biotechnology companies across the globe. BB BIOTECH's portfolio includes large stakes in half a dozen companies such as Actelion and Biogen Idec; the company also holds smaller shares in about 15 others. The firm usually makes only limited investments (not taking more than a 10% stake) in non-public companies. When considering an investment, the firm looks for key development markers. BB BIOTECH prefers to take stakes in companies that are within two years of bringing a product to market.
|
| | | Contact Information | |
Address: |
Vordergasse 3
CH-8200 Schaffhausen, Switzerland
| | Phone: | +41-52-624-08-45 | | Fax: | +41-52-624-60-29 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 69.90 M | | Revenue Growth (1 yr): | 6154.50% |
|
|
Key People
| | • |
Chairman:
Prof Thomas D. Szucs
|
|
|
